This miRNA cluster regulates, at the post-transcriptional level, different oncogenes including the myeloid cell leukemia 1 (MCL1) and the B cell CLL/B cell lymphoma 2 (BCL2), which exert an oncogenic function in this hematological disorder [88]. This evidence concerns the gene BCL2 and hematologic disorder.